Saturday , July 31 2021

Scientists discover medicine against casual blend Photo 1 of 4 | Science

The science It is full of great discoveries that came unexpectedly, incidentally, even when the phenomenon discovered was not necessarily studied.

Many of these discoveries belong to the pharmacological field, an area, in which drugs, whose side effects have unexpectedly solved other medical problems.

One of the best known examples is a viagra, which initially thought to handle the box, but if you were waiting for it, they found a side that has benefited thousands of people in the world. Another of these coincidences was penicillin or apparatuses such as the shoemaker.

Thanks to this constant curiosity and observing the ability of researchers, it is possible to detect side effects that will eventually become new drugs for the treatment of diseases other than those who were first investigated.


Throughout these lines, a team of doctors of the Massachusetts General Hospital discovered the side effects of dupilumab, a drug approved by the United States Food and Drug Administration (FDA) for treating eczema on the skin. .

The discovery, published in JAMA Dermatology and highlighted by the scientific website Eurekalert , it was revealed that when he dealt with an eczema in a drug of 13 years with the drug, he began to present positive results, but not only about the aforementioned illness, but from the alopecia he had suffered, because he was two years old and for that reason He loses all the hair on his body.

Alopecia is an acute disorder that leads to whole hair, because the immune system begins to attack the patient's hair.

The treatment, which began in July 2017, consisted of a weekly injection of the medication. After six months, the symptoms of eczema improved, but surprisingly, the patient began to present some fine hair on the scalp. During the time it passed and following the treatment, more hair appeared on its head, which also began to show pigmentation.

Even during a time when the patient had to stop the treatment due to problems with their insurance, the hair began to fall, and then grew up when he returned to the injections.


The dermatologists treating the patient have not discovered, for the moment, what is the reason for these improvements compared to the patient's alopecia. They consider that the immune path that induces an example has elements in common with that of total alopecia, and exactly exactly where dupilumab acts.

However, at present it does not know if this medicine could be used to other people suffering from this disease, but researchers have already asked to start clinical trials with more patients.

The new objective is now to reproduce the results obtained in other patients and, if positive, a new medication to solve baldness would be very close. It's just waiting.

With Hipertextual information, EurekAlert.

Source link